Type 2 diabetes mellitus, etiology and possible treatment: preliminary report

Ahren, B, Karlsson, S, Lindskog, S. Cholinergic regulation of the endocrine pancreas. In: Progress in Brain Research, Vol. 84, Chapt. 23. New York: Elsevier Science Publishers 1990:209–18 Barker, 1995, Microvascular decompression for hemifacial spasm, J Neurosurg, 82, 201, 10.3171/jns.1995.82.2.0201 Barker, 1996, The long-term outcome of microvascular decompression for trigeminal neuralgia, N Engl J Med, 334, 1077, 10.1056/NEJM199604253341701 CDC press release January 26, 2001. [Online]. http://www.cdc.gov/od/oc/media/pressrel/r010126.htm (accessed May 2001) Geiger, 1998, Decrease of blood pressure by ventrolateral medullary compression in essential hypertension, Lancet, 352, 446, 10.1016/S0140-6736(97)11343-5 Goutham, 2001, Insulin resistance syndrome, American Family Physician, 63, 1159 Groop, 2001, The dysmetabolic syndrome, J Internal Med, 250, 105, 10.1046/j.1365-2796.2001.00864.x Jannetta, 1985, Neurogenic hypertension, Ann Surg, 201, 391, 10.1097/00000658-198503000-00023 Jannetta, 1985, Neurogenic hypertension etiology and surgical treatment. II. Observations in an experimental nonhuman primate, Ann Surg, 202, 253, 10.1097/00000658-198508000-00018 Jannetta, 1992, Essential hypertension caused by arterial compression of the left lateral medulla, 107 Jannetta, PJ, Resnick, D. Cranial rhizophathies. In: Youmans JR, ed. Philadelphia: W. B. Saunders Company, 1996:3563–74 Jho, 1995, Microvascular decompression for spasmodic torticollis, Acta Neurochirurgica, 134, 21, 10.1007/BF01428497 Levy, 1998, Microvascular decompression of the left lateral medulla oblongata for severe refractory neurogenic hypertension, Neurosurgery, 43, 1, 10.1097/00006123-199807000-00001 Levy, 2001, Microvascular decompression in the treatment of hypertension, Surg Neurol, 55, 2, 10.1016/S0090-3019(00)00352-9 Liao, 1995, Association of vagal tone with serum insulin, glucose, and diabetes mellitus, Diabetes Res Clin Practice, 30, 211, 10.1016/0168-8227(95)01190-0 Li, 1998, Central CGRP inhibits pancreatic enzyme secretion by modulation of vagal parasympathetic outflow, Am J Physiol, 275, G957 Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of the type 2 diabetes mellitus: results of a 25-year follow-up study. 1992;340:925-9 Morimoto, 1997, Pulsatile compression of the rostral ventrolateral medulla in hypertension, Hypertension, 29, 514, 10.1161/01.HYP.29.1.514 Naraghi R, Geiger H, Cmac J, et al. Posterior fossa neurovascular anomalies in essential hypertension. Lancet 1994;344:1466–70 Nishizawa, 2000, The heptic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor, J Autonomic Nervous System, 80, 14, 10.1016/S0165-1838(99)00086-7 Resnick, 1995, Microvascular decompression for glossopharyngeal neuralgia, Neurosurgery, 36, 64, 10.1227/00006123-199501000-00008 Schuster, 1996, Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension, Hypertension, 28, 1085, 10.1161/01.HYP.28.6.1085 Suzuki, 2000, Regulation of pancreatic secretion by vagal nerve during short-term duct occlusion in conscious rats, Pancreas, 20, 94, 10.1097/00006676-200001000-00013 Toka, 1998, Families with autosomal dominant brachydactyly Type E, short stature and severe hypertension, Ann Internal Med, 129, 204, 10.7326/0003-4819-129-3-199808010-00008 Van Ouwerkerk, 1989, Essential hypertension in patients with hemifacial spasm or trigeminal neuralgia, Adv Neurosurg, 17, 188, 10.1007/978-3-642-74279-8_31 Reasner, 2001, Treatment of type 2 diabetes mellitus, Am Family Physician, 63, 1687